Skip Navigation LinksHome > Press

For Immediate Release
October 08, 2015
Public Relations  
+1.301.215.6526
Contact:
Transfusion Medicine, Cellular Therapies and Patient Blood Management Professionals to Gather in Anaheim to Discuss Latest Developments at the 2015 AABB Annual Meeting
MEDIA ADVISORY
WHEN:Saturday, Oct. 24 - Tuesday, Oct. 27, 2015
WHERE:Anaheim Convention Center
800 W. Katella Ave
Anaheim, Calif.

Educational programs and discussions will include:

HOT TOPIC: Management of Blood Donor Iron Depletion - New Concepts and Action

Iron depletion in blood donors is a chronic consequence of blood donation, but its health consequences are not entirely understood. Experts at this program will discuss the frequency and causes of blood donor iron deficiency and review varying opinions on current options to mitigate donor iron deficiency. In addition, this program will include data and discussion of three recently published studies from US and European investigators; the session will conclude with a panel discussion on what blood collectors should now be doing.

TTD I: Emerging Infectious Diseases — What Concerns us Today?

Several arboviral infections have emerged that are of concern to recipient safety. Experts will provide background on the emergence and surveillance of tick-borne viruses and transfusion safety concerns. In addition, the results of two key travel surveys will be discussed. These surveys were designed to provide much-needed data on the impact of a short deferral period for donors following international travel. Finally, there will be a discussion of an update to the status of investigational donor screening interventions for Babesia microti with emphasis on evolving policy.

The Ethics of Massive Transfusion

Massive transfusions can place a strain on blood product supplies. In this session experts will address the issues of resource allocation in massive transfusion scenarios, potential blood product shortages and futility of care. Patient age and gender issues and limitations on consent will also be addressed. Of special note, a pre-conference survey was sent to blood bank medical directors asking about current thinking about clinical situations across a variety of scenarios of varying complexity.

Ask the FDA & CMS/CLIA

A perennial favorite, the ‘Ask the FDA & CMS’ session provides an opportunity for discussion of FDA and Clinical Laboratory Improvement Amendments, or CLIA,  policies, regulations, guidance’s and inspection programs that are relevant provide oversight of blood and cellular therapy programs. AABB Members submitted some of their questions before the session via the AABB website.

Additional Topics of Interest will Include:
Other Highlights
  • Opening Session will feature Abraham Verghese, bestselling author, "Cutting for Stone", and Senior Association Chair at Stanford University School of Medicine.  
  • Exhibit Hall opening on Saturday – featuring more than 200 exhibiting companies

To receive a complimentary press registration, please visit the media registration section of AABB’s website, or contact the AABB Public Relations department via phone at +1.301.215.6526. Additional information on AABB's Annual Meeting can be found on our website.

# # #